Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 …

C Rondaan, V Furer, MW Heijstek, N Agmon-Levin… - RMD open, 2019 - rmdopen.bmj.com
Aim To present a systematic literature review (SLR) on efficacy, immunogenicity and safety
of vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

AC Medeiros-Ribeiro, NE Aikawa, CGS Saad… - Nature medicine, 2021 - nature.com
CoronaVac, an inactivated SARS-CoV-2 vaccine, has been approved for emergency use in
several countries. However, its immunogenicity in immunocompromised individuals has not …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

LG Rubin, MJ Levin, P Ljungman… - Clinical infectious …, 2014 - academic.oup.com
An international panel of experts prepared an evidenced-based guideline for vaccination of
immunocompromised adults and children. These guidelines are intended for use by primary …

Behcet's syndrome

SR Dalvi, R Yildirim, Y Yazici - Drugs, 2012 - Springer
Behcet's syndrome (BS) is a vasculitis, seen more commonly around the Mediterranean and
the Far East, and manifests with oral and genital ulcerations, skin lesions, uveitis, and …

Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases

S Bühler, G Eperon, C Ribi, D Kyburz… - Swiss medical …, 2015 - edoc.unibas.ch
The number of individuals with autoimmune inflammatory rheumatic diseases (AIIRDs)
treated with immunosuppressive drugs is increasing steadily. The variety of …

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic …

NE Aikawa, LVK Kupa, SG Pasoto… - The Lancet …, 2022 - thelancet.com
Background We aimed to examine the immunogenicity pattern induced by the inactivated
SARS-CoV-2 vaccine CoronaVac (Sinovac Life Sciences, Beijing, China) in SARS-CoV-2 …

Human papillomavirus vaccine and systemic lupus erythematosus

M Gatto, N Agmon-Levin, A Soriano, R Manna… - Clinical …, 2013 - Springer
To investigate the association between human papillomavirus (HPV) vaccination and
autoimmune manifestations compatible with systemic lupus erythematosus (SLE) or SLE …

Impact of distinct therapies on antibody response to SARS‐CoV‐2 vaccine in systemic lupus erythematosus

EFN Yuki, EF Borba, SG Pasoto… - Arthritis care & …, 2022 - Wiley Online Library
Objective To date, the only study that has assessed the severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2 mRNA) vaccine in systemic lupus erythematosus (SLE) …

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

AC Ribeiro, IM Laurindo, LK Guedes… - Arthritis care & …, 2013 - Wiley Online Library
Objective To evaluate the influence of abatacept (ABA) and associated contributing factors
on pandemic 2009 influenza A/H1N1 vaccine immunogenicity in rheumatoid arthritis (RA) …